Table 1.
Baseline demographics (n = 7) and results from drug susceptibility testing
| Parameter | Value |
|---|---|
| Mean age (yr) (range) | 31.0 (25.5–33.5) |
| No. (%) of male patients | 4 (57) |
| Median body wt (kg) (IQR) | 71.5 (56.0–75.3) |
| Median ht (m) (IQR) | 1.73 (1.64–1.74) |
| No. (%) of patients of ethnicity | |
| African | 5 (71) |
| Caucasian | 1 (14) |
| Asian | 1 (14) |
| No. (%) of HIV-positive patients | 1 (14) |
| No. of isolates resistant to drug based on DST/total no. of isolates | |
| Rifampin | 7/7 |
| Isoniazid | 7/7 |
| Ethambutol | 5/7 |
| Pyrazinamidea | 4/6 |
| Streptomycin | 6/7 |
| Capreomycin | 2/7 |
| Amikacin | 0/7 |
| Ciprofloxacin | 1/7 |
| Clarithromycina | 3/5 |
| Clofaziminea | 0/4 |
| Linezolid | 0/7 |
| Moxifloxacin | 1/7 |
| Protionamidea | 2/6 |
| Rifabutin | 6/7 |
a
Drug susceptibility testing (DST) was not available for all isolates of the included patients.